Racho Jordanov
President and CEO
JHL Biotech,Rancho Santa Fe
USA
Biography
Racho Jordanov Co-Founder, President and CEO. Racho Jordanov is a biotech pioneer with more than 30 years of experience building and leading manufacturing operations in development-stage and multi-national biopharmaceutical companies. Mr. Jordanov started his career with Genentech, Inc. in 1981 in San Francisco, where he led the facility start-up and managed on-going commercial manufacturing of the first biotech products to be approved by FDA: insulin and rhGH. Over his 20-year career at Genentech Mr. Jordanov was at the forefront of innovations in biopharmaceutical manufacturing, from introducing the first processes for monoclonal antibody (mAb) production, to establishing Genentech\'s outsourcing capabilities for drug substance, drug product and medical devices, to most recently starting-up new biomanufacturing facilities in the US and Singapore. In addition to Genentech, Mr. Jordanov led North America manufacturing operations for Serono S.A. (now Merck Serono; Switzerland) and served as the Vice President of Manufacturing and Operations for two California-based biotech start-ups: Cholestech and Telios Pharmaceuticals. Mr. Jordanov earned his B.S. in Chemical Engineering from the University of California, San Diego, and an M.B.A. from National University in San Diego.
Research Interest
Biotechnology, Monoclonal antibody (mAb) production, Biomanufacturing,